EYEG

Q: What is the price of EyeGate Pharmaceuticals (EYEG) today?

The current price of EyeGate Pharmaceuticals (EYEG) is $ 35.07, representing a 5.56% gain over the past year. The stock began the year trading around $ 35.77 and is currently priced at $ 35.07. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does EyeGate Pharmaceuticals (EYEG) pay dividends?

EyeGate Pharmaceuticals (EYEG) distributed dividends in the last year,in the months of January, February, March, April, May and June totaling $ 0.89. The Dividend Yield for the last 12 months is 5.00%.

EyeGate Pharmaceuticals Inc.

Price

$ 35.07

return (12m)

5.56%

p/e

-23.68

p/bv

14.24

DIVIDEND YIELD

5.00%

EYEG price

EyeGate Pharmaceuticals

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment EYEG

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-0.13%

3 months

-0.27%

1 year

5.56%

2 years

9.92%

5 years

898.09%

10 years

-6.16%

Fundamentals EYEG

review the fundamentals of EyeGate Pharmaceuticals shares

P/E

-23.68

Sector: -1.72 Industry: -5.50

P/S (PSR)

Sector: 1.97 Industry: 2.98

P/BV

14.24

Sector: 2.13 Industry: 1.95

DIVIDEND YIELD (DY)

5.00%

Sector: - Industry: -

ROA

-40.92%

Sector: -27.63% Industry: -50.45%

ROE

-60.14%

Sector: -33.26% Industry: -47.51%

ROIC

Sector: -439.47% Industry: -539.51%

NET MARGIN

-100.00%

Sector: -29.66% Industry: -36.80%

GROSS MARGIN

100.00%

Sector: 45.32% Industry: 49.57%

OPERATING MARGIN

-100.00%

Sector: -24.55% Industry: -32.48%

EV/EBITDA

-23.08

Sector: -0.34 Industry: -3.00

EV/EBIT

-22.99

Sector: -1.74 Industry: -5.20

PRICE-TO-ASSETS

9.69

Sector: 1.17 Industry: 1.27

BVPS

2.46

Sector: 3.91 Industry: 2.03

EPS

-1.48

Sector: -0.90 Industry: -1.30

EQUITY-TO-ASSETS RATIO

0.68

Sector: 0.43 Industry: 0.48

LIABILITIES / ASSETS

0.32

Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

14.87%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

5.41%

Sector: - Industry: -

Fundamentals EYEG

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	39.95	32.37	81.02%	0.55%	$ 1.01 T	34.99%
ISRG	50.29	8.51	16.93%	0.00%	$ 149.83 B	28.15%
SNY	7.36	1.31	17.79%	8.84%	$ 109.89 B	14.75%
TMO	25.68	3.38	13.15%	0.37%	$ 175.88 B	15.15%
NVS	21.04	7.31	34.77%	2.08%	$ 284.75 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$ 149.12 B	13.91%
MDT	22.71	2.13	9.38%	3.48%	$ 104.78 B	13.00%
GSK	13.10	4.42	33.77%	3.43%	$ 102.78 B	17.79%
CVS	41.65	1.57	3.78%	2.77%	$ 122.12 B	0.72%
BSX	20.36	2.81	13.78%	0.00%	$ 72.58 B	17.29%
TMDX	13.73	4.78	34.80%	0.00%	$ 2.36 B	27.04%
HCA	12.27	-27.99	-228.14%	0.79%	$ 83.36 B	8.89%
IDXX	41.06	28.90	70.38%	0.00%	$ 44.97 B	24.63%
RMD	18.65	4.37	23.41%	1.19%	$ 28.34 B	27.44%
DHR	35.37	2.46	6.97%	0.74%	$ 130.48 B	14.89%
INMD	9.78	1.29	13.18%	0.00%	$ 853.02 M	23.27%
PHG	22.01	1.88	8.56%	3.88%	$ 24.87 B	5.50%
SYK	34.98	5.08	14.52%	1.13%	$ 116.73 B	13.21%
CI	11.78	1.81	15.39%	2.10%	$ 76.49 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

EYEG Historical Dividends

current DY: 5.00%

5-year average DY: 5.00%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/29/2026	06/04/2026	0,14150000
Dividends	04/30/2026	05/06/2026	0,14040000
Dividends	03/31/2026	04/07/2026	0,14330000
Dividends	02/27/2026	03/05/2026	0,13930000
Dividends	01/30/2026	02/05/2026	0,14110000
Dividends	12/30/2025	01/05/2026	0,18530000
Dividends	11/28/2025	12/04/2025	0,13910000
Dividends	10/31/2025	11/06/2025	0,13860000
Dividends	09/30/2025	10/06/2025	0,13610000
Dividends	09/01/2025	09/05/2025	0,14170000
Dividends	07/31/2025	08/06/2025	0,14980000
Dividends	06/30/2025	07/07/2025	0,14200000
Dividends	05/30/2025	06/05/2025	0,15100000
Dividends	04/30/2025	05/06/2025	0,15010000
Dividends	03/31/2025	04/04/2025	0,15300000
Dividends	02/28/2025	03/06/2025	0,13900000
Dividends	01/31/2025	02/06/2025	0,14100000
Dividends	12/27/2024	01/02/2025	0,47100000
Dividends	11/29/2024	12/05/2024	0,14600000
Dividends	10/31/2024	11/06/2024	0,15150000
Dividends	09/30/2024	10/04/2024	0,14750000
Dividends	09/02/2024	09/06/2024	0,14920000
Dividends	07/31/2024	08/06/2024	0,15460000
Dividends	06/28/2024	07/05/2024	0,14990000
Dividends	05/31/2024	06/06/2024	0,15390000
Dividends	04/30/2024	05/07/2024	0,14840000
Dividends	03/29/2024	04/05/2024	0,15720000
Dividends	02/29/2024	03/07/2024	0,14860000
Dividends	01/31/2024	02/07/2024	0,14760000
Dividends	12/27/2023	01/04/2024	0,09130000

ABOUT EyeGate Pharmaceuticals

EyeGate Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (0 people)

United States

28 years

Founded: 1998

2015

Time since IPO - 11 years

14

Employees

EyeGate Pharmaceuticals Inc. (United States) is listed on the Nasdaq and has a market capitalization of $247.03 Millions, with shareholders equity totaling $17.35 Millions.

The company employs approximately 14 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, EyeGate Pharmaceuticals Inc. reported $24.12 Thousand in revenue, generating net income of $-10.43 Millions.

Key financial metrics include a P/E ratio of -23.68, a price-to-book (P/B) ratio of 14.24, and a trailing twelve-month dividend yield of 5.00%.

The company trades under the ticker EYEG.

Market cap

$ 247.03 Millions

Net worth

$ 17.35 Millions

$ 17,348,046.00

Assets

$ 25.49 Millions

$ 25,493,339.00

Total Shares Outstanding

7.06 Millions

7,062,000

Average Daily Trading Volume

$ 101.74

Sector

Health

Industry

Pharmaceutical Products

EYEG

EYEG revenue and profits

Financial Results EYEG

DRAG THE FRAME TO SEE MORE DATA

EYEG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 95.93 56,38% (12M)

P/E

41.65

2.77%

ROE

3.78%

P/BV

1.57

CI - Cigna

$ 289.48 --5,32% (12M)

P/E

11.78

2.10%

ROE

15.39%

P/BV

1.81

CNC - Centene

$ 62.33 13,00% (12M)

P/E

-4.76

0.00%

ROE

-29.93%

P/BV

1.42

HUM - Humana

$ 350.08 54,13% (12M)

P/E

37.18

1.01%

ROE

6.06%

P/BV

2.25

SNY - Sanofi

$ 45.02 --3,18% (12M)

P/E

7.36

8.84%

ROE

17.79%

P/BV

1.31

LLY - Eli Lilly

$ 1,131.42 47,32% (12M)

P/E

39.95

0.55%

ROE

81.02%

P/BV

32.37

HCA - HCA Healthcare

$ 372.13 --2,35% (12M)

P/E

12.27

0.79%

ROE

-228.14%

P/BV

-27.99

NVS - Novartis

$ 149.16 28,84% (12M)

P/E

21.04

2.08%

ROE

34.77%

P/BV

7.31

CVS - CVS Health

$ 95.93 56,38% (12 M)

P/L

41.65

2.77%

ROE

3.78%

P/VP

1.57

CI - Cigna

$ 289.48 --5,32% (12 M)

P/L

11.78

2.10%

ROE

15.39%

P/VP

1.81

CNC - Centene

$ 62.33 13,00% (12 M)

P/L

-4.76

0.00%

ROE

-29.93%

P/VP

1.42

HUM - Humana

$ 350.08 54,13% (12 M)

P/L

37.18

1.01%

ROE

6.06%

P/VP

2.25

SNY - Sanofi

$ 45.02 --3,18% (12 M)

P/L

7.36

8.84%

ROE

17.79%

P/VP

1.31

LLY - Eli Lilly

$ 1,131.42 47,32% (12 M)

P/L

39.95

0.55%

ROE

81.02%

P/VP

32.37

HCA - HCA Healthcare

$ 372.13 --2,35% (12 M)

P/L

12.27

0.79%

ROE

-228.14%

P/VP

-27.99

NVS - Novartis

$ 149.16 28,84% (12 M)

P/L

21.04

2.08%

ROE

34.77%

P/VP

7.31

Frequently Asked Questions

What is the price of EyeGate Pharmaceuticals (EYEG) today?

The current price of EyeGate Pharmaceuticals (EYEG) is $ 35.07, representing a 5.56% gain over the past year. The stock began the year trading around $ 35.77 and is currently priced at $ 35.07. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does EyeGate Pharmaceuticals (EYEG) pay dividends?

EyeGate Pharmaceuticals (EYEG) distributed dividends in the last year,in the months of January, February, March, April, May and June totaling $ 0.89. The Dividend Yield for the last 12 months is 5.00%.

Is EyeGate Pharmaceuticals (EYEG) a good investment?

EyeGate Pharmaceuticals (EYEG) is currently trading at $ 35.07 with a P/E ratio of -23.68. This represents a 0% premium compared to its historical average P/E. Over the past year, the stock has gained 5.56 and paid $ 0.89 in dividends, resulting in a dividend yield of 5.00%. The total shareholder return over the same period was 5.56%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy EyeGate Pharmaceuticals (EYEG) stock?

You can buy EyeGate Pharmaceuticals (EYEG) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol EYEG and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of EyeGate Pharmaceuticals (EYEG) yield today?

Over the past month, EyeGate Pharmaceuticals (EYEG) has returned -0.13% — 5.56% over the past year, and 898.09% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 1.74 per share in dividends, resulting in a dividend yield of 5.00%.

If you were to purchase 100 shares of EyeGate Pharmaceuticals (EYEG) today at the current price of $ 35.07 your total investment would be $ 3,507.00.

Based on historical performance, the investment would have grown to approximately:

$ 3,701.99 after 1 year
$ 35,003.02 after 5 years
$ 3,290.97 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

EYEG

EyeGate Pharmaceuticals Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment EYEG

review the fundamentals of EyeGate Pharmaceuticals shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

current DY: 5.00%

5-year average DY: 5.00%

type

Ex - Dividend Date

payment date

value

ABOUT EyeGate Pharmaceuticals

EyeGate Pharmaceuticals Inc.

United States

28 years

2015

14

PROFIT X PRICE EYEG

Financial Results EYEG

EYEG cash flow

Asset, Revenue and Profit Growth - EYEG

EYEG balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions